Prostate Cancer (Post Prostatectomy): Clinical Trials

4 trials for Prostate Cancer (Post Prostatectomy), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 3, Completed 1

Follow Prostate Cancer (Post Prostatectomy): new trials by email Literature Review of Prostate Cancer (Post Prostatectomy) trials Research Report on Prostate Cancer (Post Prostatectomy)

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Rezvilutamide Tablets - Prostate Cancer (Post Prostatectomy)
Phase 2RecruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School482026-07-012026-07-23
Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy
64Cu-SAR-bisPSMA - Prostate Cancer (Post Prostatectomy)
Phase 2CompletedSt Vincent's Hospital, Sydney502024-11-212026-08-14
FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
FK-PC101, Standard of Care (SOC) - Prostate Cancer (Adenocarcinoma), Prostate CA
Phase 2RecruitingCellvax Therapeutics Inc1002024-10-142024-10-21
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
18F-rhPSMA-7.3 (Posluma) - Prostate Cancer (Post Prostatectomy)
Phase 2RecruitingAdventHealth302024-09-202024-10-24

Narrower conditions

Prostatic Neoplasms (4)  ·  Adenocarcinoma (1)

Broader conditions

Genital Diseases (4)  ·  Genital Diseases, Male (4)  ·  Genital Neoplasms, Male (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Prostatic Diseases (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Carcinoma (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

Standard of Care (1)

Sponsors

AdventHealth (1)  ·  Cellvax Therapeutics Inc (1)  ·  St Vincent's Hospital, Sydney (1)  ·  The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)

Top investigators

Fernando Kreutz, MD PhD (1)

Results publications

PMID 41904043